03.07.2018 • News

Kamal Abbasi Joins Kamedis’ Board of Director

Kamedis, a provider of products for the treatment of chronic skin disorders, announced the addition of Kamal Abbasi to its board of directors. Abbasi formerly served as area vice president of Nestle Skin Health’s Galderma business for Asia Pacific. He is currently vice president at Sinclair Pharma with responsibility for Asia Pacific, Middle East/North Africa and Central/Eastern Europe.

Abbasi, a British citizen, is a medical doctor and obtained his degree from the Sindh Medical University in Karachi, Pakistan. His appointment coincides with a major growth initiative by Kamedis in Central and Eastern Europe.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.